Type1Screen

25/03/2026

Type1Screen are excited to be attending Summer Party at Funfields this Sunday 29th March. We will be offering free screening for T1D autoantibodies and answering all your questions.

If you are keen to be take part in screening for type 1 diabetes at the party, you can either register with the team on the day or you can pre-register your details at type1screen.org and hit the 'Register Online' button.

Heartfelt thanks to the Type 1 Foundation for inviting us along - we cannot wait to see you all there!

25/03/2026

Type1Screen are excited to be attending Breakthrough T1D's One Walk in Melbourne this Sunday 29th March at South Beach Reserve St Kilda. We will be offering free screening for T1D autoantibodies and answering all your questions.

If you are keen to be take part in screening for type 1 diabetes at the walk, you can either register with the team on the day or you can pre-register your details at type1screen.org and hit the 'Register Online' button.

Look forward to seeing you there!

23/03/2026

Reminder: Our Type 1 Screen colleague, Dr Mia Majstorovic will be discussing her research on the human side of early-stage diabetes monitoring and immunotherapy on Thursday afternoon at 1pm AEDT. Mia will be sharing her research on the experiences and perspectives of people with early stage type 1 diabetes, their families and health care professionals with regard to screening, monitoring and interventions. We hope to see you there. Details below:

Seminar 30, Beyond Insulin Seminar Series - Dr Mia Majstorovic from University of Adelaide presents findings of the QuEST study and how qualitative research can provide insights into service design and delivery in type 1 diabetes.

23/03/2026

Here is some information about a clinical trial for people aged 15-40 years with newly diagnosed type 1 diabetes. Details below:

Have you or someone you care for been diagnosed with type 1 diabetes in the last 100 days?
ATIC is supporting the SAFEGUARD trial to test a new treatment that aims to protect the remaining insulin producing cells.
More information is available at the ATIC website: https://atic.svi.edu.au/clinical-trials/clinical-trials/
Or contact us via the details listed below:

18/03/2026

An exciting update from Breakthrough T1D on the latest research presented at the 2026 Advanced Technologies and Treatments for Diabetes conference held in Barcelona last week. It is wonderful to see screening for type 1 diabetes, cell therapies and disease modifying therapies discussed on the global stage.

16/03/2026

Our friends at ATIC are showcasing the work of our colleague Dr Mia Majstorovic at their next seminar. If you are interested in the human side of type 1 diabetes screening, monitoring and immunotherapy, we'd love you to join us online on Thursday 26th March, 2026 at 1pm AEDT.
For more information, follow the link below: https://atic.svi.edu.au/news-events/from-narratives-to-numbers-the-human-side-of-early-stage-type-1-diabetes-monitoring-and-immunotherapy/?fbclid=IwY2xjawQkTchleHRuA2FlbQIxMQBicmlkETFrMnYxdGRqYmJNcE5zTUZyc3J0YwZhcHBfaWQQMjIyMDM5MTc4ODIwMDg5MgABHqUeMZm_YZwacXHmG9U-vbVAL4L60sXpT_NhLJIKWWDcG2VoJhUmtQ17VBHB_aem_vZFXbCltUB43lbhp1ecj5w

Seminar 30, Beyond Insulin Seminar Series - Dr Mia Majstorovic from University of Adelaide presents findings of the QuEST study and how qualitative research can provide insights into service design and delivery in type 1 diabetes.

06/03/2026

In case you missed it, catch Type1Screen's Professor John Wentworth, and colleagues, update on the latest in

Type 1 diabetes research has made huge advances, with new breakthroughs emerging all the time.Join Dr Dorota Pawlak, Breakthrough T1D Australia’s Chief Scien...

20/02/2026

🤖Can AI Chatbots Help Families Manage Type 1 Diabetes?

A new study looked at the AI tool, ChatGPT, to see if it could support families living with . Researchers at the Montreal Children’s Hospital tested how well an AI chatbot answered real questions from parents and diabetes educators about caring for children with .

✨ What they found:
✅ ChatGPT gave mostly clear, easy-to-understand answers and encouraged families to stay in touch with their diabetes care team.
✅ It could be useful for quick information, translation, and 24/7 access to support.

⚠️ But some answers missed important child-specific details — like checking for ketones when blood sugars are high or adjusting carb amounts based on a child’s weight.

💬 The takeaway:
AI chatbots can be a helpful extra support tool, but they should never replace trusted medical advice. Healthcare providers and families need to work together to ensure these tools are used safely, accurately, and responsibly.

📖 The article is available online at: https://doi.org/10.2196/76986

14/02/2026

AID systems - aka or - automatically adjust based on continuous glucose monitoring ( ) readings. But do they really work better than standard diabetes care for children and young people?

A new review analysed 11 studies involving 901 young people (aged 6-18) using AIDs for an average of 7 months, compared to standard care (manual insulin pumps or injections).

The results (AIDs vs standard care):
✅ Time in target range (TIR) increased by an average of 11.5%
✅ HbA1c dropped by 0.41% (clinically meaningful)
✅ Night-time glucose control improved dramatically; nearly 20% more TIR!
✅ Less time in both highs AND lows
✅ No increase in dangerous side effects

The night-time win is BIG:
Parents often lose sleep worrying about overnight lows and highs. AIDs showed the biggest improvements during night-time hours compared to traditional insulin management.

What we still don't know:
Only 2 studies looked at quality of life, so we need more research on how AIDs affect daily wellbeing, stress, and mental health.

Bottom line:
AIDs appear to be highly effective at improving glucose management in young people with T1D versus standard treatment, especially overnight—offering real hope for better control and potentially more peace of mind for families.

Read more at https://doi.org/10.1001/jamapediatrics.2025.2740

09/02/2026

Could CGM detect coeliac disease early? 🔍

1 in 10 children with develop coeliac disease. This often goes undiagnosed for months or years, affecting growth and health.

New research analysed continuous glucose monitoring ( ) data from children before their coeliac diagnosis and found surprising results:

📉 Kids with undiagnosed coeliac had flatter blood glucose curves after meals; glucose didn't spike as high
🥞 This pattern was especially clear after breakfast
❌ They did NOT see more low blood sugars - "hypos"

Current guidelines say to look for increased lows as a coeliac warning sign. This study says that's the WRONG signal to look for.

CGM could potentially flag unusual meal patterns that warrant coeliac testing; identifying the condition months earlier than traditional screening.

Earlier diagnosis = starting a gluten-free diet sooner = preventing complications ✨ More research is needed, but this could transform how we screen for coelia
Read more at: https://doi.org/10.1515/jpem-2025-0302

05/02/2026

🧠🧬 Why are more children developing type 1 diabetes? A new Finnish study offers clues.

Type 1 diabetes is becoming more common worldwide—especially in children—and genetic traits cannot explain the rise.

Researchers in studied over 16,000 children with (and nearly 49,000 matched without the condition) diagnosed between 1990 and 2019. Using detailed address histories, they looked at where and when children lived before diagnosis.

🔍 What did they find?
They discovered those who developed were more likely to be diagnosed close together in both time and place—a pattern called spatiotemporal clustering. This was especially strong in children older than 6 years.

🌍 Why does this matter?
Clustering like this suggests factors—such as , seasonal exposures, or other local influences—may help trigger the condition in susceptible children. It adds weight to the theory isn’t caused by genetics alone.

👶 What’s new here?
Unlike most past studies, this one used complete residential histories, even looking at where children lived in their first year of life—a critical window for immune development.

➡️ The takeaway:
This large, high-quality study strengthens the case that play a role in type 1 diabetes development. The next step is figuring out what those triggers are and when they matter most—knowledge that could one day help prevent the disease.

💬 Understanding the “where and when” could be key to changing the future of type 1 diabetes.

02/02/2026

💙 Did you know your gut microbes (normal bacteria, viruses, and fungi living in your digestive system) make tiny molecules that may talk to the immune system?

A new study followed young children from 3 months to 3 years old to see how gut bacteria and the chemicals they produce change over time and relate to early immune markers linked to development.

Here’s what they found:

🌱 Gut bugs make special bile acid compounds — not just for digestion, but also as signalling molecules.

🧠 These compounds change as children grow and which bacteria live in the gut.

🧬 Some bacterial bile acid products were different in kids who later showed early immune changes linked with .

🧡 These molecules also seemed connected to how certain immune cells behaved — including cells that help balance versus regulation.

Why this matters:
It suggests that gut bacteria and what they produce in early life might play a role in shaping the immune system in ways that relate to risk — long before appear.

This research doesn’t say what causes type 1 diabetes. It helps us understand the communication between gut microbes and immune development so we can one day support healthier beginnings 💙

Read more at: https://rdcu.be/eV6xX